Screener
Climb Bio, Inc. CLYM Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 6) | ||
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value; 250,000,000 shares authorized; 47,768,543 and 47,766,338 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 5 | 5 |
| Additional paid-in capital | 451,372 | 449,762 |
| Accumulated other comprehensive income | 157 | 435 |
| Accumulated deficit | (303,449) | (289,727) |
| Total stockholders’ equity | 148,085 | 160,475 |
| Total liabilities and stockholders’ equity | $152,372 | $167,744 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s retained earnings?
- Climb Bio, Inc. (CLYM) reported retained earnings of -$303.45M in Q1 2026.
- How has Climb Bio, Inc.'s retained earnings changed year-over-year?
- Climb Bio, Inc.'s retained earnings decreased by 21.1% year-over-year, from -$250.66M to -$303.45M.
- What is the long-term trend for Climb Bio, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Climb Bio, Inc.'s retained earnings has grown at a 59.4% compound annual growth rate (CAGR), from -$28.14M to -$289.73M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Climb Bio, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude